January 2011 Briefing - DermatologyLast Updated: February 01, 2011.
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Electronic Health Records May Not Improve Care Quality
WEDNESDAY, Jan. 26 (HealthDay News) -- Electronic health records (EHRs) and clinical decision support (CDS) do not appear to improve the quality of clinical care, according to a study published online Jan. 24 in the Archives of Internal Medicine.
Licensing Scores Correlate With Dermatology Resident Scores
TUESDAY, Jan. 24 (HealthDay News) -- United States Medical Licensing Examination (USMLE) Step 1 scores are moderately and significantly correlated with dermatology resident in-training examination (ITE) scores, according to research published in the January issue of the Journal of the American Academy of Dermatology.
Research Questions Smoking-Melanoma Link
MONDAY, Jan. 24 (HealthDay News) -- The inverse relationship between cigarette smoking and melanoma is not statistically significant after adjustment for factors including ultraviolet (UV) exposure and number of sunburns, according to a report in the January issue of the Journal of the American Academy of Dermatology.
Follow-Up Programs Tied to Early Melanoma Detection
FRIDAY, Jan. 21 (HealthDay News) -- Including patients at high risk for melanoma in follow-up programs can result in detection of early-stage disease, and a lower percentage of primary care physicians than dermatologists perform full-body skin examinations on patients, according two studies published in the January issue of the Archives of Dermatology.
Digital Ulcers Linked to More Severe Systemic Sclerosis
WEDNESDAY, Jan. 19 (HealthDay News) -- Digital ulcers are associated with more severe systemic sclerosis (SSc) disease, including skin and lung involvement, but not with pulmonary arterial hypertension (PAH) or scleroderma renal crisis (SRC), according to research published in the January issue of Arthritis Care & Research.
Sunscreen May Prevent Lesions in Photosensitive CLE Patients
TUESDAY, Jan. 18 (HealthDay News) -- Use of a broad-spectrum sunscreen may prevent skin lesions in photosensitive patients with cutaneous lupus erythematosus (CLE), according to research published in the January issue of the Journal of the American Academy of Dermatology.
Severe Maternal Psoriasis Linked to Low Birth Weight
TUESDAY, Jan. 18 (HealthDay News) -- Women with severe psoriasis are 1.4 times more likely to have a low birth weight (LBW) infant, but mild psoriasis is not related to an increased risk of adverse birth outcomes, according to a study published in the January issue of the Journal of the American Academy of Dermatology.
CDC Report Highlights Important Health Disparities
THURSDAY, Jan. 13 (HealthDay News) -- Among Americans, disparities in income, race and ethnicity, gender, and other social attributes have an impact on whether an individual is healthy or ill or will die prematurely, according to a report by the U.S. Centers for Disease Control and Prevention, released as a supplement to the Jan. 14 issue of the Morbidity and Mortality Weekly Report.
Burnout Levels Particularly High in Residents
MONDAY, Jan. 10 (HealthDay News) -- The incidence of burnout and risk for burnout are high in physicians, particularly residents, and more than a quarter of anesthesiology chairs meet criteria for high burnout, according to two articles published in the January issue of Anesthesiology.
Alopecia Studied in Mycosis Fungoides/Sézary Syndrome
FRIDAY, Jan. 7 (HealthDay News) -- In patients with mycosis fungoides (MF) and Sézary syndrome (SS), 2.5 percent have alopecia, according to a retrospective study published in the January issue of the Journal of the American Academy of Dermatology.
Severe Skin Lesions Can Cause IBD Patients to Quit Therapy
WEDNESDAY, Jan. 5 (HealthDay News) -- Severe skin lesions cause patients with inflammatory bowel disease (IBD) to discontinue anti-tumor necrosis factor-α (TNF-α) therapy, according to research published in the December issue of Clinical Gastroenterology and Hepatology.